A Pilot Trial of Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With DLBCL
Phase of Trial: Phase I
Latest Information Update: 25 Feb 2019
Price : $35 *
At a glance
- Drugs Blinatumomab (Primary) ; Carmustine; Cytarabine; Etoposide; Melphalan
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 18 Feb 2019 Planned End Date changed from 30 Sep 2021 to 31 Dec 2022.
- 18 Feb 2019 Planned primary completion date changed from 31 Jan 2019 to 31 Dec 2019.
- 02 Aug 2017 Status changed from not yet recruiting to recruiting.